EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Chembio Diagnostics's enterprise value is $23.61 Mil.
Chembio Diagnostics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was $-20.89 Mil. Therefore, Chembio Diagnostics's EV-to-EBITDA for today is -1.13.
The historical rank and industry rank for Chembio Diagnostics's EV-to-EBITDA or its related term are showing as below:
CEMI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -109.43 Med: -7.47 Max: 42.83
Current: -1.13
During the past 13 years, the highest EV-to-EBITDA of Chembio Diagnostics was 42.83. The lowest was -109.43. And the median was -7.47.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Chembio Diagnostics EV-to-EBITDA Historical Data
The historical data trend for Chembio Diagnostics's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Chembio Diagnostics's EV-to-EBITDA
For the Diagnostics & Research subindustry, Chembio Diagnostics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chembio Diagnostics's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chembio Diagnostics's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Chembio Diagnostics's EV-to-EBITDA falls into.
Chembio Diagnostics's current Enterprise Value is $23.61 Mil.
Chembio Diagnostics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.89 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Chembio Diagnostics's PE Ratio for today is calculated as:
Chembio Diagnostics's share price for today is $0.455.
Chembio Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.720.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Chembio Diagnostics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Chembio Diagnostics (Chembio Diagnostics) Business Description
Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CEMI has been successfully added to your 